Global PVA Foam Embolization Particles Market Insights and Forecast to 2026

Global PVA Foam Embolization Particles Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 PVA Foam Embolization Particles Product Introduction
1.2 Market Segments
1.3 Key PVA Foam Embolization Particles Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global PVA Foam Embolization Particles Market Size Growth Rate by Type
1.4.2 50µm~350µm
1.4.3 350µm~560µm
1.4.4 560µm~710µm
1.4.5 710µm~1000µm
1.4.6 1000µm~1400µm
1.4.7 1400µm~2000µm
1.5 Market by Application
1.5.1 Global PVA Foam Embolization Particles Market Size Growth Rate by Application
1.5.2 Uterine Fibroid Embolization
1.5.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.5.4 Liver Tumor Embolization
1.5.5 Trauma Embolization
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global PVA Foam Embolization Particles Market Size, Estimates and Forecasts
2.1.1 Global PVA Foam Embolization Particles Revenue 2015-2026
2.1.2 Global PVA Foam Embolization Particles Sales 2015-2026
2.2 Global PVA Foam Embolization Particles, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global PVA Foam Embolization Particles Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global PVA Foam Embolization Particles Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global PVA Foam Embolization Particles Competitor Landscape by Players
3.1 PVA Foam Embolization Particles Sales by Manufacturers
3.1.1 PVA Foam Embolization Particles Sales by Manufacturers (2015-2020)
3.1.2 PVA Foam Embolization Particles Sales Market Share by Manufacturers (2015-2020)
3.2 PVA Foam Embolization Particles Revenue by Manufacturers
3.2.1 PVA Foam Embolization Particles Revenue by Manufacturers (2015-2020)
3.2.2 PVA Foam Embolization Particles Revenue Share by Manufacturers (2015-2020)
3.2.3 Global PVA Foam Embolization Particles Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by PVA Foam Embolization Particles Revenue in 2019
3.2.5 Global PVA Foam Embolization Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 PVA Foam Embolization Particles Price by Manufacturers
3.4 PVA Foam Embolization Particles Manufacturing Base Distribution, Product Types
3.4.1 PVA Foam Embolization Particles Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers PVA Foam Embolization Particles Product Type
3.4.3 Date of International Manufacturers Enter into PVA Foam Embolization Particles Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global PVA Foam Embolization Particles Market Size by Type (2015-2020)
4.1.1 Global PVA Foam Embolization Particles Sales by Type (2015-2020)
4.1.2 Global PVA Foam Embolization Particles Revenue by Type (2015-2020)
4.1.3 PVA Foam Embolization Particles Average Selling Price (ASP) by Type (2015-2026)
4.2 Global PVA Foam Embolization Particles Market Size Forecast by Type (2021-2026)
4.2.1 Global PVA Foam Embolization Particles Sales Forecast by Type (2021-2026)
4.2.2 Global PVA Foam Embolization Particles Revenue Forecast by Type (2021-2026)
4.2.3 PVA Foam Embolization Particles Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global PVA Foam Embolization Particles Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global PVA Foam Embolization Particles Market Size by Application (2015-2020)
5.1.1 Global PVA Foam Embolization Particles Sales by Application (2015-2020)
5.1.2 Global PVA Foam Embolization Particles Revenue by Application (2015-2020)
5.1.3 PVA Foam Embolization Particles Price by Application (2015-2020)
5.2 PVA Foam Embolization Particles Market Size Forecast by Application (2021-2026)
5.2.1 Global PVA Foam Embolization Particles Sales Forecast by Application (2021-2026)
5.2.2 Global PVA Foam Embolization Particles Revenue Forecast by Application (2021-2026)
5.2.3 Global PVA Foam Embolization Particles Price Forecast by Application (2021-2026)
6 North America
6.1 North America PVA Foam Embolization Particles by Country
6.1.1 North America PVA Foam Embolization Particles Sales by Country
6.1.2 North America PVA Foam Embolization Particles Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America PVA Foam Embolization Particles Market Facts & Figures by Type
6.3 North America PVA Foam Embolization Particles Market Facts & Figures by Application
7 Europe
7.1 Europe PVA Foam Embolization Particles by Country
7.1.1 Europe PVA Foam Embolization Particles Sales by Country
7.1.2 Europe PVA Foam Embolization Particles Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe PVA Foam Embolization Particles Market Facts & Figures by Type
7.3 Europe PVA Foam Embolization Particles Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific PVA Foam Embolization Particles by Region
8.1.1 Asia Pacific PVA Foam Embolization Particles Sales by Region
8.1.2 Asia Pacific PVA Foam Embolization Particles Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific PVA Foam Embolization Particles Market Facts & Figures by Type
8.3 Asia Pacific PVA Foam Embolization Particles Market Facts & Figures by Application
9 Latin America
9.1 Latin America PVA Foam Embolization Particles by Country
9.1.1 Latin America PVA Foam Embolization Particles Sales by Country
9.1.2 Latin America PVA Foam Embolization Particles Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America PVA Foam Embolization Particles Market Facts & Figures by Type
9.3 Central & South America PVA Foam Embolization Particles Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa PVA Foam Embolization Particles by Country
10.1.1 Middle East and Africa PVA Foam Embolization Particles Sales by Country
10.1.2 Middle East and Africa PVA Foam Embolization Particles Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa PVA Foam Embolization Particles Market Facts & Figures by Type
10.3 Middle East and Africa PVA Foam Embolization Particles Market Facts & Figures by Application
11 Company Profiles
11.1 Cook Medical
11.1.1 Cook Medical Corporation Information
11.1.2 Cook Medical Description and Business Overview
11.1.3 Cook Medical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cook Medical PVA Foam Embolization Particles Products Offered
11.1.5 Cook Medical Related Developments
11.2 Sirtex Medical
11.2.1 Sirtex Medical Corporation Information
11.2.2 Sirtex Medical Description and Business Overview
11.2.3 Sirtex Medical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sirtex Medical PVA Foam Embolization Particles Products Offered
11.2.5 Sirtex Medical Related Developments
11.3 Merit Medical
11.3.1 Merit Medical Corporation Information
11.3.2 Merit Medical Description and Business Overview
11.3.3 Merit Medical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merit Medical PVA Foam Embolization Particles Products Offered
11.3.5 Merit Medical Related Developments
11.4 BTG Medical
11.4.1 BTG Medical Corporation Information
11.4.2 BTG Medical Description and Business Overview
11.4.3 BTG Medical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BTG Medical PVA Foam Embolization Particles Products Offered
11.4.5 BTG Medical Related Developments
11.5 Boston Scientific Corporation
11.5.1 Boston Scientific Corporation Corporation Information
11.5.2 Boston Scientific Corporation Description and Business Overview
11.5.3 Boston Scientific Corporation Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Boston Scientific Corporation PVA Foam Embolization Particles Products Offered
11.5.5 Boston Scientific Corporation Related Developments
11.6 Terumo Corporation
11.6.1 Terumo Corporation Corporation Information
11.6.2 Terumo Corporation Description and Business Overview
11.6.3 Terumo Corporation Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Terumo Corporation PVA Foam Embolization Particles Products Offered
11.6.5 Terumo Corporation Related Developments
11.7 HENGRUI Medical
11.7.1 HENGRUI Medical Corporation Information
11.7.2 HENGRUI Medical Description and Business Overview
11.7.3 HENGRUI Medical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 HENGRUI Medical PVA Foam Embolization Particles Products Offered
11.7.5 HENGRUI Medical Related Developments
11.8 INterface BIOmaterials B.V.
11.8.1 INterface BIOmaterials B.V. Corporation Information
11.8.2 INterface BIOmaterials B.V. Description and Business Overview
11.8.3 INterface BIOmaterials B.V. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 INterface BIOmaterials B.V. PVA Foam Embolization Particles Products Offered
11.8.5 INterface BIOmaterials B.V. Related Developments
11.9 Alicon
11.9.1 Alicon Corporation Information
11.9.2 Alicon Description and Business Overview
11.9.3 Alicon Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Alicon PVA Foam Embolization Particles Products Offered
11.9.5 Alicon Related Developments
11.1 Cook Medical
11.1.1 Cook Medical Corporation Information
11.1.2 Cook Medical Description and Business Overview
11.1.3 Cook Medical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cook Medical PVA Foam Embolization Particles Products Offered
11.1.5 Cook Medical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 PVA Foam Embolization Particles Market Estimates and Projections by Region
12.1.1 Global PVA Foam Embolization Particles Sales Forecast by Regions 2021-2026
12.1.2 Global PVA Foam Embolization Particles Revenue Forecast by Regions 2021-2026
12.2 North America PVA Foam Embolization Particles Market Size Forecast (2021-2026)
12.2.1 North America: PVA Foam Embolization Particles Sales Forecast (2021-2026)
12.2.2 North America: PVA Foam Embolization Particles Revenue Forecast (2021-2026)
12.2.3 North America: PVA Foam Embolization Particles Market Size Forecast by Country (2021-2026)
12.3 Europe PVA Foam Embolization Particles Market Size Forecast (2021-2026)
12.3.1 Europe: PVA Foam Embolization Particles Sales Forecast (2021-2026)
12.3.2 Europe: PVA Foam Embolization Particles Revenue Forecast (2021-2026)
12.3.3 Europe: PVA Foam Embolization Particles Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific PVA Foam Embolization Particles Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: PVA Foam Embolization Particles Sales Forecast (2021-2026)
12.4.2 Asia Pacific: PVA Foam Embolization Particles Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: PVA Foam Embolization Particles Market Size Forecast by Region (2021-2026)
12.5 Latin America PVA Foam Embolization Particles Market Size Forecast (2021-2026)
12.5.1 Latin America: PVA Foam Embolization Particles Sales Forecast (2021-2026)
12.5.2 Latin America: PVA Foam Embolization Particles Revenue Forecast (2021-2026)
12.5.3 Latin America: PVA Foam Embolization Particles Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa PVA Foam Embolization Particles Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: PVA Foam Embolization Particles Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: PVA Foam Embolization Particles Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: PVA Foam Embolization Particles Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key PVA Foam Embolization Particles Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 PVA Foam Embolization Particles Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. PVA Foam Embolization Particles Market Segments
Table 2. Ranking of Global Top PVA Foam Embolization Particles Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global PVA Foam Embolization Particles Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of 50µm~350µm
Table 5. Major Manufacturers of 350µm~560µm
Table 6. Major Manufacturers of 560µm~710µm
Table 7. Major Manufacturers of 710µm~1000µm
Table 8. Major Manufacturers of 1000µm~1400µm
Table 9. Major Manufacturers of 1400µm~2000µm
Table 10. Global PVA Foam Embolization Particles Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global PVA Foam Embolization Particles Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global PVA Foam Embolization Particles Sales by Regions 2015-2020 (K Units)
Table 13. Global PVA Foam Embolization Particles Sales Market Share by Regions (2015-2020)
Table 14. Global PVA Foam Embolization Particles Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global PVA Foam Embolization Particles Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global PVA Foam Embolization Particles Sales Share by Manufacturers (2015-2020)
Table 17. Global PVA Foam Embolization Particles Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global PVA Foam Embolization Particles by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PVA Foam Embolization Particles as of 2019)
Table 19. PVA Foam Embolization Particles Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. PVA Foam Embolization Particles Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers PVA Foam Embolization Particles Price (2015-2020) (USD/Unit)
Table 22. PVA Foam Embolization Particles Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers PVA Foam Embolization Particles Product Type
Table 24. Date of International Manufacturers Enter into PVA Foam Embolization Particles Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global PVA Foam Embolization Particles Sales by Type (2015-2020) (K Units)
Table 27. Global PVA Foam Embolization Particles Sales Share by Type (2015-2020)
Table 28. Global PVA Foam Embolization Particles Revenue by Type (2015-2020) (US$ Million)
Table 29. Global PVA Foam Embolization Particles Revenue Share by Type (2015-2020)
Table 30. PVA Foam Embolization Particles Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global PVA Foam Embolization Particles Sales by Application (2015-2020) (K Units)
Table 32. Global PVA Foam Embolization Particles Sales Share by Application (2015-2020)
Table 33. North America PVA Foam Embolization Particles Sales by Country (2015-2020) (K Units)
Table 34. North America PVA Foam Embolization Particles Sales Market Share by Country (2015-2020)
Table 35. North America PVA Foam Embolization Particles Revenue by Country (2015-2020) (US$ Million)
Table 36. North America PVA Foam Embolization Particles Revenue Market Share by Country (2015-2020)
Table 37. North America PVA Foam Embolization Particles Sales by Type (2015-2020) (K Units)
Table 38. North America PVA Foam Embolization Particles Sales Market Share by Type (2015-2020)
Table 39. North America PVA Foam Embolization Particles Sales by Application (2015-2020) (K Units)
Table 40. North America PVA Foam Embolization Particles Sales Market Share by Application (2015-2020)
Table 41. Europe PVA Foam Embolization Particles Sales by Country (2015-2020) (K Units)
Table 42. Europe PVA Foam Embolization Particles Sales Market Share by Country (2015-2020)
Table 43. Europe PVA Foam Embolization Particles Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe PVA Foam Embolization Particles Revenue Market Share by Country (2015-2020)
Table 45. Europe PVA Foam Embolization Particles Sales by Type (2015-2020) (K Units)
Table 46. Europe PVA Foam Embolization Particles Sales Market Share by Type (2015-2020)
Table 47. Europe PVA Foam Embolization Particles Sales by Application (2015-2020) (K Units)
Table 48. Europe PVA Foam Embolization Particles Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific PVA Foam Embolization Particles Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific PVA Foam Embolization Particles Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific PVA Foam Embolization Particles Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific PVA Foam Embolization Particles Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific PVA Foam Embolization Particles Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific PVA Foam Embolization Particles Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific PVA Foam Embolization Particles Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific PVA Foam Embolization Particles Sales Market Share by Application (2015-2020)
Table 57. Latin America PVA Foam Embolization Particles Sales by Country (2015-2020) (K Units)
Table 58. Latin America PVA Foam Embolization Particles Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa PVA Foam Embolization Particles Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America PVA Foam Embolization Particles Revenue Market Share by Country (2015-2020)
Table 61. Latin America PVA Foam Embolization Particles Sales by Type (2015-2020) (K Units)
Table 62. Latin America PVA Foam Embolization Particles Sales Market Share by Type (2015-2020)
Table 63. Latin America PVA Foam Embolization Particles Sales by Application (2015-2020) (K Units)
Table 64. Latin America PVA Foam Embolization Particles Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa PVA Foam Embolization Particles Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa PVA Foam Embolization Particles Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa PVA Foam Embolization Particles Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa PVA Foam Embolization Particles Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa PVA Foam Embolization Particles Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa PVA Foam Embolization Particles Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa PVA Foam Embolization Particles Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa PVA Foam Embolization Particles Sales Market Share by Application (2015-2020)
Table 73. Cook Medical Corporation Information
Table 74. Cook Medical Description and Major Businesses
Table 75. Cook Medical PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Cook Medical Product
Table 77. Cook Medical Recent Development
Table 78. Sirtex Medical Corporation Information
Table 79. Sirtex Medical Description and Major Businesses
Table 80. Sirtex Medical PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Sirtex Medical Product
Table 82. Sirtex Medical Recent Development
Table 83. Merit Medical Corporation Information
Table 84. Merit Medical Description and Major Businesses
Table 85. Merit Medical PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Merit Medical Product
Table 87. Merit Medical Recent Development
Table 88. BTG Medical Corporation Information
Table 89. BTG Medical Description and Major Businesses
Table 90. BTG Medical PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. BTG Medical Product
Table 92. BTG Medical Recent Development
Table 93. Boston Scientific Corporation Corporation Information
Table 94. Boston Scientific Corporation Description and Major Businesses
Table 95. Boston Scientific Corporation PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Boston Scientific Corporation Product
Table 97. Boston Scientific Corporation Recent Development
Table 98. Terumo Corporation Corporation Information
Table 99. Terumo Corporation Description and Major Businesses
Table 100. Terumo Corporation PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Terumo Corporation Product
Table 102. Terumo Corporation Recent Development
Table 103. HENGRUI Medical Corporation Information
Table 104. HENGRUI Medical Description and Major Businesses
Table 105. HENGRUI Medical PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. HENGRUI Medical Product
Table 107. HENGRUI Medical Recent Development
Table 108. INterface BIOmaterials B.V. Corporation Information
Table 109. INterface BIOmaterials B.V. Description and Major Businesses
Table 110. INterface BIOmaterials B.V. PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. INterface BIOmaterials B.V. Product
Table 112. INterface BIOmaterials B.V. Recent Development
Table 113. Alicon Corporation Information
Table 114. Alicon Description and Major Businesses
Table 115. Alicon PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Alicon Product
Table 117. Alicon Recent Development
Table 118. Global PVA Foam Embolization Particles Sales Forecast by Regions (2021-2026) (K Units)
Table 119. Global PVA Foam Embolization Particles Sales Market Share Forecast by Regions (2021-2026)
Table 120. Global PVA Foam Embolization Particles Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 121. Global PVA Foam Embolization Particles Revenue Market Share Forecast by Regions (2021-2026)
Table 122. North America: PVA Foam Embolization Particles Sales Forecast by Country (2021-2026) (K Units)
Table 123. North America: PVA Foam Embolization Particles Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Europe: PVA Foam Embolization Particles Sales Forecast by Country (2021-2026) (K Units)
Table 125. Europe: PVA Foam Embolization Particles Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Asia Pacific: PVA Foam Embolization Particles Sales Forecast by Region (2021-2026) (K Units)
Table 127. Asia Pacific: PVA Foam Embolization Particles Revenue Forecast by Region (2021-2026) (US$ Million)
Table 128. Latin America: PVA Foam Embolization Particles Sales Forecast by Country (2021-2026) (K Units)
Table 129. Latin America: PVA Foam Embolization Particles Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Middle East and Africa: PVA Foam Embolization Particles Sales Forecast by Country (2021-2026) (K Units)
Table 131. Middle East and Africa: PVA Foam Embolization Particles Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 133. Key Challenges
Table 134. Market Risks
Table 135. Main Points Interviewed from Key PVA Foam Embolization Particles Players
Table 136. PVA Foam Embolization Particles Customers List
Table 137. PVA Foam Embolization Particles Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. PVA Foam Embolization Particles Product Picture
Figure 2. Global PVA Foam Embolization Particles Sales Market Share by Type in 2020 & 2026
Figure 3. 50µm~350µm Product Picture
Figure 4. 350µm~560µm Product Picture
Figure 5. 560µm~710µm Product Picture
Figure 6. 710µm~1000µm Product Picture
Figure 7. 1000µm~1400µm Product Picture
Figure 8. 1400µm~2000µm Product Picture
Figure 9. Global PVA Foam Embolization Particles Sales Market Share by Application in 2020 & 2026
Figure 10. Uterine Fibroid Embolization
Figure 11. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Figure 12. Liver Tumor Embolization
Figure 13. Trauma Embolization
Figure 14. Other
Figure 15. PVA Foam Embolization Particles Report Years Considered
Figure 16. Global PVA Foam Embolization Particles Market Size 2015-2026 (US$ Million)
Figure 17. Global PVA Foam Embolization Particles Sales 2015-2026 (K Units)
Figure 18. Global PVA Foam Embolization Particles Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global PVA Foam Embolization Particles Sales Market Share by Region (2015-2020)
Figure 20. Global PVA Foam Embolization Particles Sales Market Share by Region in 2019
Figure 21. Global PVA Foam Embolization Particles Revenue Market Share by Region (2015-2020)
Figure 22. Global PVA Foam Embolization Particles Revenue Market Share by Region in 2019
Figure 23. Global PVA Foam Embolization Particles Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by PVA Foam Embolization Particles Revenue in 2019
Figure 25. PVA Foam Embolization Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global PVA Foam Embolization Particles Sales Market Share by Type (2015-2020)
Figure 27. Global PVA Foam Embolization Particles Sales Market Share by Type in 2019
Figure 28. Global PVA Foam Embolization Particles Revenue Market Share by Type (2015-2020)
Figure 29. Global PVA Foam Embolization Particles Revenue Market Share by Type in 2019
Figure 30. Global PVA Foam Embolization Particles Market Share by Price Range (2015-2020)
Figure 31. Global PVA Foam Embolization Particles Sales Market Share by Application (2015-2020)
Figure 32. Global PVA Foam Embolization Particles Sales Market Share by Application in 2019
Figure 33. Global PVA Foam Embolization Particles Revenue Market Share by Application (2015-2020)
Figure 34. Global PVA Foam Embolization Particles Revenue Market Share by Application in 2019
Figure 35. North America PVA Foam Embolization Particles Sales Growth Rate 2015-2020 (K Units)
Figure 36. North America PVA Foam Embolization Particles Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America PVA Foam Embolization Particles Sales Market Share by Country in 2019
Figure 38. North America PVA Foam Embolization Particles Revenue Market Share by Country in 2019
Figure 39. U.S. PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 40. U.S. PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 42. Canada PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America PVA Foam Embolization Particles Market Share by Type in 2019
Figure 44. North America PVA Foam Embolization Particles Market Share by Application in 2019
Figure 45. Europe PVA Foam Embolization Particles Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe PVA Foam Embolization Particles Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe PVA Foam Embolization Particles Sales Market Share by Country in 2019
Figure 48. Europe PVA Foam Embolization Particles Revenue Market Share by Country in 2019
Figure 49. Germany PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 52. France PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe PVA Foam Embolization Particles Market Share by Type in 2019
Figure 60. Europe PVA Foam Embolization Particles Market Share by Application in 2019
Figure 61. Asia Pacific PVA Foam Embolization Particles Sales Growth Rate 2015-2020 (K Units)
Figure 62. Asia Pacific PVA Foam Embolization Particles Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific PVA Foam Embolization Particles Sales Market Share by Region in 2019
Figure 64. Asia Pacific PVA Foam Embolization Particles Revenue Market Share by Region in 2019
Figure 65. China PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 66. China PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 68. Japan PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 70. South Korea PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 72. India PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 74. Australia PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 76. Taiwan PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 78. Indonesia PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 80. Thailand PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 82. Malaysia PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 84. Philippines PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 86. Vietnam PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific PVA Foam Embolization Particles Market Share by Type in 2019
Figure 88. Asia Pacific PVA Foam Embolization Particles Market Share by Application in 2019
Figure 89. Latin America PVA Foam Embolization Particles Sales Growth Rate 2015-2020 (K Units)
Figure 90. Latin America PVA Foam Embolization Particles Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America PVA Foam Embolization Particles Sales Market Share by Country in 2019
Figure 92. Latin America PVA Foam Embolization Particles Revenue Market Share by Country in 2019
Figure 93. Mexico PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 94. Mexico PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 96. Brazil PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs